Your Mounjaro price guide · October 2026
Can Mounjaro Help With Sleep Apnea? What the Trials Show (October 2026)
Yes, Mounjaro can help obstructive sleep apnoea in adults with obesity: in the SURMOUNT-OSA trials, breathing interruptions fell by around half or more over a year, and some participants improved enough to no longer need the same level of treatment.16 Results vary, and it works alongside diet and activity. If you use CPAP, continue it. Current as of October 2026.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
The short version
Mounjaro is a weight-management medicine, and in adults with obesity its effect on obstructive sleep apnoea (apnea) has been studied directly.
- Price includes prescriber assessment and standard delivery — no consultation fees
- Orders approved by 3pm for next-day tracked delivery
- GPhC-registered pharmacy 9012878
- Needles and sharps disposal included
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
Mounjaro (tirzepatide) substantially reduced obstructive sleep apnoea severity in adults with obesity in the SURMOUNT-OSA trials.
-
The benefit is linked to weight loss, so it applies to sleep apnoea in people living with obesity, not to every cause of disturbed sleep.
-
Obstructive sleep apnoea counts as a weight-related condition in the eligibility criteria.
-
If you use CPAP, continue it and keep your sleep clinic informed.
-
Mounjaro is prescription-only and supplied after a consultation reviewed by a GPhC-registered prescriber.
In this guide
01 · The core answer
Does Mounjaro help with sleep apnoea?
Yes, for adults with obesity and obstructive sleep apnoea, the evidence is encouraging. In the SURMOUNT-OSA trials, tirzepatide substantially reduced the severity of obstructive sleep apnoea in adults with obesity — on average, breathing interruptions fell by around half or more over a year, and some participants improved enough to no longer need the same level of treatment.16
Those are trial averages, so they do not predict your own result. Some people improve a great deal, others less. Mounjaro is used alongside a reduced-calorie diet and increased physical activity, not instead of them.2
It is also worth being clear about what it does not do. Mounjaro is a weight-management medicine. It is not a replacement for a sleep assessment, and it is not a treatment for snoring or poor sleep that has other causes. If you want the wider picture on sleep quality, see our guide on whether Mounjaro helps sleep.
02 · Your decision
Is this relevant to you?
It is most relevant if you have been diagnosed with obstructive sleep apnoea, you are living with obesity, and you are already thinking about weight-loss treatment. Obstructive sleep apnoea also counts as a weight-related condition in the eligibility criteria.16 That matters because Mounjaro is licensed in the UK for weight management in adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition such as obstructive sleep apnoea.1
If you have not been diagnosed but you snore loudly, wake unrefreshed or have been told you stop breathing in your sleep, speak to your GP first. A sleep assessment, not a weight-loss injection, is the right first step. For the prescribing side, read how Mounjaro is prescribed where sleep apnoea is involved.
If you are ready to explore treatment, you can start a free consultation for the Mounjaro pen. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and a prescriber reviews every request. You can also see our wider weight loss clinic.
Related guide: Does mounjaro help you sleep better.
03 · How it helps
How does Mounjaro help sleep apnoea?
Mounjaro helps mainly by supporting weight loss in adults with obesity. The trial authors studied tirzepatide specifically in adults with obesity and obstructive sleep apnoea, and the results were a substantial reduction in severity.16
The medicine works by activating the GIP and GLP-1 receptors, which are natural gut-hormone receptors. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.1
In practice, the medicine supports a lower calorie intake, weight comes down, and in the SURMOUNT-OSA trials breathing interruptions during sleep fell.16
04 · What the trials found
What SURMOUNT-OSA found
SURMOUNT-OSA is the trial programme that tested tirzepatide in adults with obesity and obstructive sleep apnoea. The headline finding is that, on average, breathing interruptions fell by around half or more over a year.16 Some participants improved enough to no longer need the same level of treatment.16
It is worth reading that carefully. "Around half or more" is an average across participants. It does not mean every person halved their breathing interruptions, and it does not mean sleep apnoea disappeared. Some people had a smaller change and some had a larger one.
The weight-loss results behind this are separate and come from a different trial, so they should not be added together. In SURMOUNT-1 of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.2 These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.2
For a worked example only: for someone starting at 100 kg, 20.9% is about 21 kg. That is straight arithmetic on a trial average, not a forecast of what you will lose.
05 · CPAP and treatment
Should I stop CPAP if I take Mounjaro?
No. If you use CPAP, continue it and keep your sleep clinic informed.16 Mounjaro is not a reason to stop or change sleep apnoea treatment on your own.
What happens next is a conversation with your sleep clinic. As your weight changes, they may want to reassess how severe your sleep apnoea is and whether your current level of treatment is still right for you. That is a decision for your clinic, based on a repeat assessment, and not something to guess at from how you feel.
It helps to tell your sleep clinic when you start Mounjaro, and to tell our prescribing team about your sleep apnoea and any CPAP use during your consultation. Everything you share is reviewed by a GPhC-registered prescriber. Our ongoing monthly reviews also give you a regular point to raise how your sleep is going.
06 · Reversing sleep apnoea
Can you reverse sleep apnoea by losing weight?
Weight loss can substantially reduce the severity of obstructive sleep apnoea in people with obesity, and in the trials some participants improved enough to no longer need the same level of treatment.16 That is not the same as a promise of reversal, and results vary.
Weight loss is also something you need to maintain. Stopping treatment can mean weight returns: in SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year.14 Talk to your prescriber about what long-term treatment looks like before you begin.
If you are weighing up other injectable options, our guides to weight loss injections for sleep apnoea and the wider GLP-1 class and sleep apnoea cover the comparison.
07 · Getting it on the NHS
Can you get Mounjaro for sleep apnoea on the NHS?
Mounjaro is available on the NHS, but access is being phased in over several years.6 NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).4
Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.4 Ask your GP where you sit in your local rollout.
If you choose private treatment, a free online consultation is reviewed by a GPhC-registered prescriber, and unsuitable orders are refunded automatically. Our pharmacy is GPhC-registered (9012878) and supplies genuine Mounjaro KwikPens through official LillyDirect supply.
08 · Other sleep tips
What about pillow tricks, vitamins and drinks?
Be cautious of any product or technique that promises to cure sleep apnoea quickly or without assessment, and treat dramatic claims as a warning sign.
If you notice a new symptom after starting any medicine, discuss it with your prescriber, and you can report suspected side effects through the MHRA Yellow Card scheme.19
09 · Next steps
What to do next
Start with your diagnosis. If you have not had a sleep assessment and you suspect sleep apnoea, see your GP. If you have been diagnosed, tell your sleep clinic you are considering Mounjaro and keep using CPAP if you have it.
If weight loss treatment is right for you, the process is straightforward. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Approved orders are dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm and free next-day tracked delivery in temperature-controlled packaging.
Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.
10 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamCan Mounjaro help with sleep apnoea?
How does tirzepatide help sleep apnoea?
Which weight loss medicines are licensed in the UK?
Can you reverse sleep apnoea by losing weight?
Should I stop CPAP if I start Mounjaro?
What other conditions does Mounjaro treat?
Is there one best treatment for sleep apnoea?
Is Mounjaro for sleep apnoea available on the NHS?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 6 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- Malhotra A, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA). N Engl J Med 2024;391:1193–1205
- MHRA Yellow Card scheme — report a side effect
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


